Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.33
-0.26 (-2.24%)
At close: Apr 28, 2026, 4:00 PM EDT
11.34
+0.01 (0.09%)
After-hours: Apr 28, 2026, 7:13 PM EDT

Phathom Pharmaceuticals Market Cap

Phathom Pharmaceuticals has a market cap or net worth of $899.94 million as of April 28, 2026. Its market cap has increased by 164.82% in one year.

Market Cap
899.94M
Enterprise Value
1.36B
1-Year Change
164.82%
Ranking
Category
Stock Price
$11.33

Market Cap Chart

Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $899.94M, an increase of 70.73%. That is a compound annual growth rate of 8.56%.

History

DateMarket Cap% Change
Apr 28, 2026901.13M-23.64%
Dec 31, 20251.18B112.56%
Dec 31, 2024555.22M6.22%
Dec 29, 2023522.72M13.23%
Dec 30, 2022461.63M-22.48%
Dec 31, 2021595.53M-36.35%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Omeros 974.11M
Geron 961.35M
CytomX Therapeutics 957.85M
Annexon 955.54M
Xencor 951.94M
Fortrea Holdings 916.30M
Evommune 914.15M
Janux Therapeutics 913.08M
Market Cap Rankings